Drug reference
vorozole
Nonsteroidal Aromatase Inhibitor (Type II) · Antineoplastic
Nonsteroidal Aromatase Inhibitor (Type II)Antineoplastic
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Not yet extracted
Indications
treatment of breast cancer
Side effects
Common
hot flashes
Serious
- increased risk of osteoporosis
Related guidelines
Ask House about vorozole
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team